Gastrointestinal Stromal Tumor (GIST) Market: Size, Growth, and Regional Outlook 2026-2033
The Gastrointestinal Stromal Tumor (GIST) market is witnessing robust momentum driven by innovations in targeted therapies and expanding awareness globally. Industry trends indicate an increasing focus on personalized treatment approaches, with significant clinical advancements shaping market dynamics. The evolving market landscape reflects strategic interactions among prominent market players to address emerging market challenges and capitalize on new opportunities.
Market Size and Overview
The gastrointestinal stromal tumor (GIST) market is estimated to be valued at USD 1.32 Bn in 2025 and is expected to reach USD 2.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.
https://www.coherentmi.com/industry-reports/gastrointestinal-stromal-tumor-gist-market
The Gastrointestinal Stromal Tumor (GIST) market is witnessing robust momentum driven by innovations in targeted therapies and expanding awareness globally. Industry trends indicate an increasing focus on personalized treatment approaches, with significant clinical advancements shaping market dynamics. The evolving market landscape reflects strategic interactions among prominent market players to address emerging market challenges and capitalize on new opportunities.
Market Size and Overview
The gastrointestinal stromal tumor (GIST) market is estimated to be valued at USD 1.32 Bn in 2025 and is expected to reach USD 2.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.
https://www.coherentmi.com/industry-reports/gastrointestinal-stromal-tumor-gist-market
Gastrointestinal Stromal Tumor (GIST) Market: Size, Growth, and Regional Outlook 2026-2033
The Gastrointestinal Stromal Tumor (GIST) market is witnessing robust momentum driven by innovations in targeted therapies and expanding awareness globally. Industry trends indicate an increasing focus on personalized treatment approaches, with significant clinical advancements shaping market dynamics. The evolving market landscape reflects strategic interactions among prominent market players to address emerging market challenges and capitalize on new opportunities.
Market Size and Overview
The gastrointestinal stromal tumor (GIST) market is estimated to be valued at USD 1.32 Bn in 2025 and is expected to reach USD 2.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.
https://www.coherentmi.com/industry-reports/gastrointestinal-stromal-tumor-gist-market